English | Español

Trending
+ Regulatory
Patient Daily | Feb 11, 2026

Riley Gaines on 340B: It 'was meant to help vulnerable patients, but it’s being abused by hospitals'
+ Pharmaceuticals
Patient Daily | Feb 9, 2026

Companies advance new Duchenne muscular dystrophy treatments amid scrutiny over existing gene therapies
+ Pharmaceuticals
Patient Daily | Feb 8, 2026

Biohaven outlines new strategy after setbacks and prepares muscle-sparing drug study
+ Pharmaceuticals
Patient Daily | Feb 10, 2026

Amgen ends partnership with Kyowa Kirin on autoimmune drug rocatinlimab

No Results